mebufotenin intranasal (GH003)
/ GH Research
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 30, 2026
A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.
(PubMed, J Psychopharmacol)
- "This systematic review highlights key variations in absorption, distribution, and elimination between the studied compounds that may have important implications in both clinical and research settings."
Journal • PK/PD data • Review
March 25, 2026
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.
(PubMed, CNS Drugs)
- No abstract available
Journal • CNS Disorders • Depression • Mood Disorders • Psychiatry
November 07, 2025
Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults.
(PubMed, Sci Rep)
- "5-MeO-DMT has a distinctive profile of subjective effects relative to published reports of other psychedelics, with a short duration of action, relative lack of visual effects, strong emotional or bodily experiences and the potential to elicit therapeutically relevant content, such as emotional breakthroughs and personal insights. These findings inform therapeutic applications, participant preparation, and future research on 5-MeO-DMT."
Clinical • Journal
1 to 3
Of
3
Go to page
1